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P&ran emission tomography. This imaging merhod of- 
fers the unique opportunity for serial noninvasive \tudics of 
myacardial perfusion and metabolism in patients who have 
had a rcvasculariza~ion procedure such as coronary an+ 
plasly (l.2). Using one of several radiotracers. it pravidcr 
perfusion scans, and may be applied to the quentitation of 
myocardial blood flow (3). In addition. it yields images 
reflecting the myocardial utilization of F-18 deoxyglucosc. a 
gh~case analog. Because glnco% is the preferred subsrrute of 
the myocardium under hypoxic condilions. i1s uptake may 
be increased in ischcmic myocardium. Although some iweb- 
tigators (4) have advocated the routine clinsal UFC of 
positron emission tomography. a polenrial limitation ic ils 
cost. whose magnitude has nol ercaped the attcntlon of 
federal regulators. private insurers and the lay press (51. 
The investigators at Vniversity of California. Los i\nge- 
les (61 reported previously that the results of prcopcraux 
positron emission tomography predicted improvement in 
wall motion after coronary artery bypass gi-dfting. A~IIOQ 
myocardial segments with abnormal preoperalive wall mo- 
tion, wall motion was improved postoperatively in 85% of 
segments wilh normal or high preoperative F-18 deonyglu- 
case uptake. but in only 7% of segments with low preoper- 
ative uptake. Low uptake had much grealer predictive value 
foriack of improvement in wall motion than did the prebcnce 
of Q waves or of akinesia or dyskinesia. The% findings were 
confirmed by Tamaki et al. 17) and support the conccpl of 
chronically ischemic or “hibernating” myocardium 18.91. 
The present study. Nienaber et al. (IO) prospectively 
assessed regional myocardml perfusion and metabohqm with 
positron emission tomography and contractile function wth 
echocardiogwphy in I? patients undrrgoing percutaneous 
lransluminal coronary angioplsbty. Only paticnro with a wall 
motion abnormality at rest and metabolism-perfusion “mi+ 
match” (that is. normal or enhanced glucose uptake and 
reduced perfusion) wcrc included. The htghly select nawe 
of the \iud> group i> emphasizrd by rhe prcscnce. m 7 of the 
IZ patienti. of ST segment and T wwc abnonnalitie\ at rest 
that normalized afrcr coronary ang~oplasry. For the group of 
pariern\. [he mean level of perfusion to atlected myocardium 
Imprwcd beruieen the preitngioplasty and sarly postangio- 
plasl!: lxnhm several days) srudies and did not chanp 
belasun Ihc e&ly postangioplasty study and the late study (2 
months afier angioplasty). In contrast. the group mean wall 
mohon core was unchanged early after angioplasty bur 
improved significantly berween the early and late follow-up 
studres The group mean F-IR deoxyglucore uprakr was 
hl_eher in risk than in reference myocardium before and early 
a~lilrr angiopla\ty bm had normahzcd ar late follo\wp. The 
magnircde of preangioplew metabolism-perfusion mis- 
match correlated with the amount of improvcmcnt m wall 
molion on thr late echocardiogram. 
Tllir 11 cll r~nn$sr0vl nrtd wrel srudv 110s n fnl, wcnk- 
w.ws. Nrsnabcr ct al. (101 claim Ihat their findmgs “indi- 
cate the persistence of ::r~ abnormal metabolic and funcrmnal 
bldlt: early after rcrtorarion of blood Roar.” lf the metabolic 
and functional abnormahtxs are indeed linked. a\ the state- 
inem implies. one would expect a direct correlation bewcen 
early changs in _~Iucobe uptake and early change m wall 
motion YXXC. Inspccrion of the data in rhcir Table ! indi- 
colts. if wlhing. an inwrsr corretanon. As examples. 
Patienr 2. who had rhs geawsl degree of early normalizarion 
of abnormally high glucose uptake. bad early deterioration of 
wall malion. Whereas Patient 7. who had the most dramatic 
early improvement in wall motion. had an early increase in 
abnormally high glucose uptake. In addition, there was no 
correlation between metabolic and functional lmprovcment 
bcr\ieen rhe early and late postangioplasty studies. 
rl vetwr~rl ncnkrrcss of /kc str& is the small number of 
patient> who completed the study protocol. Coronary an& 
plasty WL III general successful. although the increasc in 
crtwxccriona~ area was minimal for the l&M in two 
paucnts: ;an additional patient required early coronary artery 
hvpasa grafting because of thrombosis al the angioplasty 
site. and another palient had a small myocardial infarction as 
a result of side-bmnch occlusion. Rertenosis occurred in wo 
pawntx. Two othrr patients r&bed late followip posmon 
emixkn lumography. In all. only tivr palients had clca~lq 
wcce~~rul and uncomplicnled angioplasty. lax positron 
emlssion iomography and no reslenosi,. 
There KH marked improvement in wall motion in 4 of IZ 
paltcnts early after coronary anglaplasty; it would be inter- 
rating to know whether there were soy idemifiable features 
that di&guishsd this group. T&\o of rhese four pa&n& had 
total ~csscI occlusiun before angioplasty. implying that 
collilwral ~esscls wcrc present: however. Nienaber et al. 
IlO\ do nil, indicate whether the presence of collateral 
ve\scl, atfected the temporal response to angioplasty. It 
would alho be imeresGng to know whether akin% and even 
dyskinew rather than mcrcly hypokmctic zones had im- 
proved wll motion after angmplasty. 
Implications. Because metabolism-perfusion mismatch 
predicts improvement in wall molion afler surgical rcvasco- 
larization. it is no, surprising that it does so after nonsurgical 
revarculariration. However, the present study (IO) makes 
important contributtons la our understanding of the time 
course of recovery of perfusion. function and metabolism 
after revascularization. Although perfusion nnages had im. 
proved by the time of the early poslangiopleaty study, they 
had not completely normalized. Of 20 myocardisl segments 
judged to be ischemic by virtue of having reduced perfusion 
but normal or enhanced glucose metabolism before angio- 
plasty, IO remained ischemic by positron emission tomo- 
graphic crileria early after angioplasty. Nienaber el al. (IO1 
pon~t out rhar lhis phenomenon may be due lo a technical 
artifact, but the fmding is consistent with the data of Manyari 
et al. (1 I). who studied 43 patienls without restenosis after 
coronary angioplarty and determined that 12 had reversible 
thallium defects on an exercise test 4 lo I8 days after the 
procedure. Thus, abnormal perfusion imaging early after 
angioplasty does not necessarily indicate that the process of 
reblcnosis has begun. 
The present study extends for the firs1 time to humans the 
finding that recovery of myacardial contractile function may 
be delayed after restoration of perfusion. The results differ 
somewhat from those of Cohen et al. 1121, who performed 
left vemriculography immediately before and after coronary 
angiaplasty in I2 patients who had wall motion abnormalities 
with chnical evidence for reversibility; they found early 
improvement in regional wall motion in 10 of the I2 patien:s 
(as opposed to 4 of 12 in the present study). The results of 
the present study are also in contrast lo those of Topol et al. 
(13). who assessed regional IcR ventricular wall thickening 
by intraoperative transesophageal and postoperative trans- 
thoracic echocardiography in 20 patients undergoing coro- 
nary arlery bypass grafting. Of 37 severely dysfunctional 
myocardial segments. 21 improved before the patients len 
the operating room; there was no further improvement at the 
time of hospilal discharge. 
Ihe jndings of this study WP tmlikc/y to Ituw u rwjor 
impact 0t1 sekctior~ of pnticrm for coronci~ cm~ioplrsty, Jbr 
werul rrosons: II although Nienaber et al. (IO) demon- 
strated a statistically significant correlation between the 
magnitude of mekabolism-perfusion mismatch and extent of 
improvement in wall motion. the predictive value of this 
index for the individual patient has not been assessed: 2) 
most patients undergoing angioplasty have normal wall 
motion or hypokinesia rather than akinesia or dyskinesia in 
the affected zone. indicating the presence of viable myocar- 
dium without the need for further studies; 3) the usual 
indication for coronary angioplasly is relief of ischemic 
symptoms, in which case demonstration of viability is not 
critical: 4) although the potential benefit of angioplasly 
decreases with the amount of viable myocardium in the 
affected zone. so does the risk of the procedure: therefore 
the benefit/risk ratio is influenced 10 a lesser degree; and 5) it 
may be possible to assebs myocardial viability. when it is at 
issue. with less expensive techniques, such as thallium 
scintipraphy with. if needed. late imaging (14) or reinjection 
of the isotope (IS). 
The results of this study, if confirmed by those of a larger 
series, do have implications for the subset of patients who 
undergo coronary angioplasty in the presence of left ventric- 
ular contractile dysfunction 116.17). The findings of the 
present (10) and previous (12.18) studies suggest that, in 
addition to reliefof ischemia, there may be improvement in 
contractile function in these oatients. Some oatients with 
contractile dysfunction are managed with multivessel angio- 
plasly 117). The finding of Nienaber et al. (IO) that recovery 
of contractile function may be delayed beyond a few days 
would lend support to a strategy of staged angioplasty, with 
dilation of the vessel supplying myocardium with the most 
abnormal wall motion first, and dilation of other vessels 
deferred for at least several days. This procedure would 
allow for greater recovery of function in the reperfused zone. 
and consequently mitigate the adverse consequences of 
acute occlusion of another vessel. 
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